πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 218 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12384753

17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12358921

Antiviral heterocyclic compounds

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12297209

Benzodiazepine derivatives as RSV inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12281140

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12268694

Combination pharmaceutical agents as RSV inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12264159

Functionalized heterocycles as antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12162857

Antiviral compounds

Enanta Pharmaceuticals, Inc. Β· Granted Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12145941

Heterocyclic antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12054493

Hepatitis B antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12018017

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12011425

Hepatitis B antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11993600

Saturated spirocyclics as antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11970502

Macrocyclic antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11958879

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11952389

Benzodiazepine derivatives as RSV inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11945824

Heterocyclic compounds as anti-viral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11945830

Antiviral heterocyclic compounds

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11919910

Spiropyrrolidine derived antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11912695

Benzodiazepine derivatives as RSV inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11912714

Spiropyrrolidine derived antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11891393

Functionalized heterocycles as antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11834436

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use th

Enanta Pharmaceuticals, Inc. Β· Granted Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11760755

Hepatitis B antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11738019

Substituted heterocycles as antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted